https://www.selleckchem.com/products/d-1553.html
tic system might provide higher patient comfort, a less invasive treatment option, and lower radiation exposure. Testicular germ cell tumor (TGCT) is the most curable solid tumor and most common cancer among men 18-39 years. While cisplatin-based chemotherapy has significantly lengthened the survival of patients with TGCT, it is associated with a high rate of thromboembolic events (TEE). To summarize our single-center experience highlighting patients who were diagnosed with TGCT and received platinum-based chemotherapy, with special atte
Like
Comment
Share
